What is the ROE (Return on Equity) of CSL this year?
The ROE of CSL this year is 0.15 undefined.
CSL ROE 2024
CSL ROE
0.15
Ticker
CSL.AX
ISIN
AU000000CSL8
WKN
890952
In 2024, CSL's return on equity (ROE) was 0.15, a -1.62% increase from the 0.15 ROE in the previous year.
CSL Aktienanalyse
What does CSL do?
CSL Ltd is a global leading company in the field of biological medicine, manufacturing a wide range of products used in the therapy of diseases. The company is based in Melbourne, Australia, and is one of the largest biotech companies in the country. CSL was founded in 1916 by Australian researcher Frank Macfarlane Burnet. Originally named Commonwealth Serum Laboratories, the company focused on the research and production of vaccines. CSL was then privatized in 1994 and changed its name to CSL Ltd. CSL's business model is based on the production of protein products and plasma derivatives used in immunotherapy, hematology, and transplantation medicine. The company specializes in the production and marketing of products in three main areas: plasma products, vaccines, and animal health. CSL's plasma division includes a variety of products, including intravenous immunoglobulins (IVIG), platelets, and alpha-1 antitrypsin. The company operates a number of plasma centers in the US and Europe to collect raw materials for these products. In the vaccine sector, CSL is primarily involved in the manufacture of influenza vaccines and also offers a range of other vaccines, including vaccines against snake bites and encephalitis. In the field of animal health, CSL produces animal vaccines to prevent viral infections in livestock such as pigs, poultry, and cattle. CSL is committed to research and development to develop new products and improve existing ones. The company has a long history in the research and development of vaccines and immunotherapies and has established a strong presence in this field. The company employs over 27,000 people in 35 countries worldwide and operates production facilities in Australia, the US, Europe, and Asia. CSL's headquarters are located in Parkville, a suburb of Melbourne, Australia. CSL has an impressive track record in terms of growth and profitability and is a stable market leader in its field. The company has achieved solid growth rates in recent years and generated a revenue of $8.5 billion in 2019. CSL is a key player in the global healthcare industry and has established a reputation as a reliable supplier of medical products and services. The company is committed to developing innovative solutions to advance medical progress and make a positive contribution to human health. CSL ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding CSL's Return on Equity (ROE)
CSL's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing CSL's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
CSL's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in CSL’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about CSL stock
How has the Return on Equity (ROE) of CSL developed compared to the previous year?
The ROE of CSL has increased by -1.62% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of CSL?
A high ROE indicates that CSL generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of CSL?
A low ROE can indicate that CSL is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of CSL affect the company?
A change in ROE (Return on Equity) of CSL can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of CSL?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of CSL?
Some factors that can influence CSL's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does CSL pay?
Over the past 12 months, CSL paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CSL is expected to pay a dividend of 4.22 USD.
What is the dividend yield of CSL?
The current dividend yield of CSL is .
When does CSL pay dividends?
CSL pays a quarterly dividend. This is distributed in the months of April, October, April, October.
How secure is the dividend of CSL?
CSL paid dividends every year for the past 26 years.
What is the dividend of CSL?
For the upcoming 12 months, dividends amounting to 4.22 USD are expected. This corresponds to a dividend yield of 2.11 %.
In which sector is CSL located?
CSL is assigned to the 'Health' sector.
Wann musste ich die Aktien von CSL kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of CSL from 10/2/2024 amounting to 2.203 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.
When did CSL pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of CSL in the year 2023?
In the year 2023, CSL distributed 3.715 USD as dividends.
In which currency does CSL pay out the dividend?
The dividends of CSL are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The CSL stock can be added to a savings plan with the following providers: Consorsbank
Andere Kennzahlen von CSL
Our stock analysis for CSL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
